Zerodha (Trading Account)
FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
Zerodha (Trading Account)
FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
|
|
Comparision between IFL Enterprises Rights Issue 2024 and Solara Active Pharma Sciences Rights Issue 2024.
Find important information like Listing Exchange, Terms of payment and Entitlement Ratio for IFL Enterprises Rights Issue 2024 and Solara Active Pharma Sciences Rights Issue 2024. IFL Enterprises Rights Issue 2024 is listed on BSE while Solara Active Pharma Sciences Rights Issue 2024 is listed on BSE, NSE.
| Ifl Enterprises Ltd | Solara Active Pharma Sciences Ltd | |
|---|---|---|
| Logo |  |
 |
| Listing At | BSE | BSE, NSE |
| Terms of Payment | Full amount of Rs. 18 per Equity Share is payable on application. |
Issue Price of Rs.375/- per share is payable as Rs.131.25 per share on Application. The remaining amount will be called within 24 months from the date of allotment in the Issue or within such extended period as may be determined by the Board or Rights Issue Committee of the Company at its sole discretion from time to time. |
| Entitlement | 198 Rights Equity Share(s) for every 100 fully paid-up Equity Shares held on Record Date | 1 Rights Equity Share(s) for every 3 fully paid-up Equity Shares held on Record Date |
| Application Form | Application Form  |
Application Form |
| Letter of Offer | Letter of Offer |
Letter of Offer |
| Registrar | Skyline Financial Services Private Ltd | Cameo Corporate Services Limited |
| Lead Managers | Choice Capital Advisors Pvt Ltd |
The issue size of IFL Enterprises Rights Issue 2024 rights issue is ₹49.53 Crores, whereas Solara Active Pharma Sciences Rights Issue 2024 rights issue size is ₹449.95 Crores.
| Ifl Enterprises Ltd | Solara Active Pharma Sciences Ltd | |
|---|---|---|
| Issue Size | 49,52,69,896 shares | 1,19,98,755 shares |
| Issue Size (Amount) | ₹49.53 Crores | ₹449.95 Crores |
| Issue Price | ₹1 per share | ₹375 per share |
| Face Value | ₹1 per share | ₹10 per share |
Find all the important dates related to the rights issue. The record date of IFL Enterprises Rights Issue 2024 is May 17, 2024 while record date of Solara Active Pharma Sciences Rights Issue 2024 is May 15, 2024.
| Ifl Enterprises Ltd | Solara Active Pharma Sciences Ltd | |
|---|---|---|
| Record Date | May 17, 2024 | May 15, 2024 |
| Credit of Rights Entitlements | May 23, 2024 | May 27, 2024 |
| Bid/Offer Opens On | May 27, 2024 | May 28, 2024 |
| Renunciation of Rights Entitlements | Jun 20, 2024 | Jun 05, 2024 |
| Bid/Offer Closes On | Jun 25, 2024 | Jun 11, 2024 |
| Deemed Date of Allotment | Jul 03, 2024 | Jun 19, 2024 |
| Credit Date | Jul 08, 2024 | Jun 19, 2024 |
| Listing Date | Jul 11, 2024 | Jun 20, 2024 |
Comparison of IFL Enterprises Rights Issue 2024 and Solara Active Pharma Sciences Rights Issue 2024 financial data, including total revenue, PAT, and net worth. The table below also includes a list of all relevant documents like the Application Form and Letter of Offer. Related Parties like Lead Manager and Registrar are also mentioned in this section.
| Ifl Enterprises Ltd | Solara Active Pharma Sciences Ltd | ||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financial | Ifl Enterprises Ltd Financial Information (Restated Consolidated)
|
Solara Active Pharma Sciences Ltd Financial Information (Restated Consolidated)Solara Active Pharma Sciences Ltd's revenue increased by 13.82% and profit after tax (PAT) rose by 61.85% between the financial year ending with March 31, 2023 and March 31, 2022.
|
|||||||||||||||||||||||||||||||||||||||||
Add a public comment...
FREE Intraday Trading (Eq, F&O)
Flat ₹20 Per Trade in F&O
|
|
